Logo image of MGAM

MOBILE GLOBAL ESPORTS INC (MGAM) Stock Fundamental Analysis

NASDAQ:MGAM - Nasdaq - US6073711011 - Common Stock - Currency: USD

0.113  0 (-1.74%)

After market: 0.085 -0.03 (-24.78%)

Fundamental Rating

1

Overall MGAM gets a fundamental rating of 1 out of 10. We evaluated MGAM against 71 industry peers in the Entertainment industry. While MGAM seems to be doing ok healthwise, there are quite some concerns on its profitability. MGAM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MGAM had negative earnings in the past year.
MGAM had a negative operating cash flow in the past year.
MGAM Yearly Net Income VS EBIT VS OCF VS FCFMGAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 -500K -1M

1.2 Ratios

Looking at the Return On Assets, with a value of -68.16%, MGAM is doing worse than 84.42% of the companies in the same industry.
Looking at the Return On Equity, with a value of -75.56%, MGAM is doing worse than 62.34% of the companies in the same industry.
Industry RankSector Rank
ROA -68.16%
ROE -75.56%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MGAM Yearly ROA, ROE, ROICMGAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 -20 -40 -60 -80

1.3 Margins

MGAM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGAM Yearly Profit, Operating, Gross MarginsMGAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, MGAM has more shares outstanding
The debt/assets ratio for MGAM is higher compared to a year ago.
MGAM Yearly Shares OutstandingMGAM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
MGAM Yearly Total Debt VS Total AssetsMGAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2M 4M 6M 8M

2.2 Solvency

MGAM has an Altman-Z score of -0.29. This is a bad value and indicates that MGAM is not financially healthy and even has some risk of bankruptcy.
MGAM has a worse Altman-Z score (-0.29) than 63.64% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MGAM is not too dependend on debt financing.
MGAM's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. MGAM outperforms 70.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACCN/A
MGAM Yearly LT Debt VS Equity VS FCFMGAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 8.43 indicates that MGAM has no problem at all paying its short term obligations.
MGAM has a Current ratio of 8.43. This is amongst the best in the industry. MGAM outperforms 96.10% of its industry peers.
MGAM has a Quick Ratio of 8.43. This indicates that MGAM is financially healthy and has no problem in meeting its short term obligations.
MGAM's Quick ratio of 8.43 is amongst the best of the industry. MGAM outperforms 96.10% of its industry peers.
Industry RankSector Rank
Current Ratio 8.43
Quick Ratio 8.43
MGAM Yearly Current Assets VS Current LiabilitesMGAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MGAM have decreased strongly by -284.29% in the last year.
EPS 1Y (TTM)-284.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-351.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

MGAM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.55% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-200%
EPS Next 2Y-85.16%
EPS Next 3Y4.55%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGAM Yearly Revenue VS EstimatesMGAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M
MGAM Yearly EPS VS EstimatesMGAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MGAM. In the last year negative earnings were reported.
Also next year MGAM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGAM Price Earnings VS Forward Price EarningsMGAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGAM Per share dataMGAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-85.16%
EPS Next 3Y4.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MGAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOBILE GLOBAL ESPORTS INC

NASDAQ:MGAM (4/17/2024, 8:12:29 PM)

After market: 0.085 -0.03 (-24.78%)

0.113

0 (-1.74%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-12 2023-05-12/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.67%
Ins Owner Change0%
Market Cap2.39M
Analysts82.86
Price Target1.02 (802.65%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.42
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.16%
ROE -75.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.43
Quick Ratio 8.43
Altman-Z -0.29
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-284.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-351.6%
EPS Next Y-200%
EPS Next 2Y-85.16%
EPS Next 3Y4.55%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-432.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-216.67%
EBIT Next 3Y-61.98%
EBIT Next 5Y30.26%
FCF growth 1Y-3550%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3500%
OCF growth 3YN/A
OCF growth 5YN/A